Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Talis Biomedical Corp changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 2 | −15 |
| Shares | 789.5K | 4.27K | 248.8K | −536.4K (−68.3%) |
| Value | $6.84M | $37.0K | $460.4K | −$6.34M (−93.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Talis Biomedical Corp at the end of Q3 2024 but not at the end of Q2 2024.
None.
Sold out (15)
Institutions that held Talis Biomedical Corp at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Baker Bros. Advisors LP | 508,323 | $4.40M |
| DME Capital Management, LPSuperinvestorGreenlight Capital | 149,052 | $1.29M |
| Vanguard Group Inc | 31,013 | $268.6K |
| Prelude Capital Management, LLC | 14,928 | $129.3K |
| Geode Capital Management, LLC | 14,020 | $123.4K |
| Renaissance Technologies LLC | 12,299 | $106.5K |
| Susquehanna International Group, LLP | 11,607 | $102.1K |
| Tower Research Capital LLC (TRC) | 877 | $7.60K |
| Morgan Stanley | 87 | $754 |
| Advisor Group Holdings, Inc. | 84 | $727 |
| Larson Financial Group LLC | 14 | $121 |
| Bank of America Corp | 13 | $113 |
| UBS Group AG | 11 | $95 |
| JPMorgan Chase & Co | 3 | $26 |
| Qube Research & Technologies Ltd | 2 | $18 |
Not filed for Q3 2024 yet (1)
Institutions that held Talis Biomedical Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 4,271 | $37.0K |